COMP <GO>
VRSN vs VRSK // EV/EBITDA & P/E VALUATION
VeriSign Inc. (NASDAQ) VS. Verisk Analytics Inc. (NASDAQ) • 15-METRIC TALLY: VRSN 6
— VRSK 8
▲ EV/EBITDA & P/E VALUATION LEADER: VRSK
LAST: $307.21 (+0.41%) • MKT CAP: $27.44B
valuation
25.1x
LAST: $196.30 (+2.93%) • MKT CAP: $24.82B
valuation
16.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VRSN VS. VRSK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VRSN | VRSK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 88.20% | 69.90% | +18.30 | VRSN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 40.30% | 53.50% | -13.20 | VRSK | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 25.1x | 16.2x | +8.90 | VRSK | /valuation <GO> |
| Free Cash Flow Yield | 3.89% | 4.80% | -0.91 | VRSK | /fcf-yield <GO> |
| Operating Margin | 67.70% | 43.70% | +24.00 | VRSN | /operating-margins <GO> |
| Net Profit Margin | 49.80% | 29.60% | +20.20 | VRSN | /net-margins <GO> |
| Revenue Growth (YoY) | 6.40% | 6.60% | -0.20 | VRSK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.78% | 1.01% | -0.23 | VRSK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 5.60 | -5.15 | VRSK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | VRSN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.6 | 55.1 | +1.50 | VRSN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.21 | 1.26 | -0.05 | VRSK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.9x | 25.4x | +5.50 | VRSK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $27.44B | $24.82B | $2.62B | VRSN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VRSN REV | VRSK REV | VRSN GROSS % | VRSK GROSS % | VRSN FCF | VRSK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.66B | $3.07B | 88.2% | 69.9% | $1.07B | $1.19B |
| FY 2024 | $1.56B | $2.88B | 87.7% | 68.7% | $874.5M | $920.1M |
| FY 2023 | $1.49B | $2.68B | — | — | $786.6M | $940.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VRSN // BETA 1.21
VRSK // BETA 1.26